Physician profile
Bruce A Bever
NPI 1841723145
$3,524.78
in general payments reported to CMS, 2019-2025
14 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $593 · 2020: $428 · 2021: $206 · 2022: $766 · 2023: $525 · 2024: $613 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,532.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,001.43 | 2019-2024 | Grafix, Oasis, Stravix Pl |
| Kerecis Limited | $536.68 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Medwest Associates | $528.43 | 2019 | |
| Arteriocyte Medical Systems, INC. | $331.51 | 2025 | Magellan |
| Treace Medical Concepts, INC. | $238.49 | 2024-2025 | |
| Royal Biologics, INC. | $189.48 | 2022 | |
| Stryker Corporation | $179.51 | 2020 | |
| Acera Surgical, INC. | $140.64 | 2022-2023 | Restrata Wound Matrix |
| Anika Therapeutics, INC. | $135.50 | 2024 | Toe Motion, Sports Medicine, Tactoset |
| Organogenesis INC. | $97.75 | 2023 | Puraply |
| Bioventus LLC | $46.73 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $46.53 | 2019 | |
| Depuy Synthes Sales INC. | $35.99 | 2023-2025 | Motoband |
| Osteomed LLC | $16.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Bever listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.